rs1555747776
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_000154.2(GALK1):c.1012dupG(p.Val338GlyfsTer65) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000154.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Deficiency of galactokinase Pathogenic:1Uncertain:1
This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with GALK1-related conditions (PMID: 10790206). ClinVar contains an entry for this variant (Variation ID: 551344). This variant disrupts the C-terminus of the GALK1 protein. Other variant(s) that disrupt this region (p.Pro362Trpfs*37) have been determined to be pathogenic (Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. This sequence change results in a frameshift in the GALK1 gene (p.Val338Glyfs*65). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 55 amino acid(s) of the GALK1 protein and extend the protein by 9 additional amino acid residues. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at